You can edit almost every page by Creating an account and confirming your email.

Harris Eyre

From EverybodyWiki Bios & Wiki




Harris Eyre is an Australian convergence medicine executive with a special focus in mental health, brain health and late life. He is an ex Forbes 30 Under 30.[1] and UCLA Fulbright Scholar[2].

Originally from tropical Australia, Harris is a physician-executive and innovator on a mission. His mission is to end the ‘one size fits all’ approach to mental health, brain health and late-life health issues with personalized and precise approaches to care. He believes major improvements in patient outcomes will come from the convergence of proven, novel and emerging solutions such as genomics, Big Data, digital tools and other deep technologies.[3]

He takes a fresh approach to his work leveraging expertise in precision medicine,[4] clinical care,[5] entrepreneurship,[6] public health, convergence science,[7] consumer participation,[8] workforce development[9] and diplomacy[10]

Eyre is co-editing a forthcoming book with Oxford University Press titled 'Convergence Mental Health: A Roadmap towards Trandisciplinary Innovation and Entrepreneurship', due 2020. Other co-editors include Helen Lavretsky (UCLA professor), Chip Reynolds III (University of Pittsburgh emeritus professor)[11] and Michael Berk (Deakin University professor).

Education

Dr Eyre completed his undergraduate medical degree (Bachelor of Medicine, Bachelor of Surgery (MBBS) at James Cook University in North Queensland, Australia.[12] His medical education specialized in rural, remote, Indigenous and Tropical health. He then completed his PhD in Neuroscience at the University of Adelaide. During his PhD, he was awarded the W.G. Walker Fulbright Scholarship to study at UCLA.[13] He undertook training in psychiatry at Barwon Health,[14] Geelong, Victoria, Australia and The Townsville Hospital,[15] Townsville, Queensland, Australia. He undertook training in medical management at Royal Melbourne Hospital,[16] Melbourne, Victoria, Australia.

Career

Industry

Harris has held a number of industry positions during his career.

Eyre is the Co-Founder and Chief Medical Officer of CNSdose, a company focused on personalized medication guidance.[17] CNSdose is noted for being the first mental health pharmacogenetics company to incorporate blood-brain-barrier genetics and the first company to secure a positive Randomized Controlled Trial.[18] In 2018, the US Department of Veterans Affairs Health Administration noted CNSdose technology as ‘the most promising in an early field’.[19] CNSdose is a Texas Medical Center Venture Fund Portfolio Company.[20]

Academic

Eyre has a strong academic track record having published 80 + articles and chapters[21] and maintaining various advisory or adjunct roles.

In his research career, he has authored numerous ground-breaking works including publishing the ‘Mental Health Innovation Diplomacy’ model,[22] the 'Phase-specific Neuroimmune Model of Depression',[23] the first meta-analysis of chemokines in depression,[24] the first meta-analysis of pharmacogenetic-based decision support tools for depression,[25] the first RCT of yoga to prevent dementia,[26] the model of 'Convergence Psychiatry'.[27]

He maintains advisory roles with Stanford’s Brainstorm Lab for Mental Health Innovation,[28] American Psychiatric Association’s Innovation Committee, The University of Melbourne, The University of Adelaide and Deakin University.

His academic work has been noted in the New York Times,[29] Newsweek,[30] Australian Financial Review[31] and other leading media outlets[32] .

Awards

Eyre has been awarded numerous awards throughout his career including 2018 Forbes 30 Under 30 Asia Listing,[33] 2015 W.G. Walker Fulbright Scholar (Highest-ranked Australian Postgraduate Scholar), 2017 Victorian State Finalist for Young Australian of the Year,[34] 2017 Outstanding Early Career Alumni Award for the College of Medicine and Dentistry at James Cook University.[35]

References

  1. "Harris Eyre". Forbes. Retrieved 2019-12-01.
  2. "Dr Harris Eyre: a multi-faceted career while at UCLA". Fulbright. 2015-09-21. Retrieved 2019-12-01.
  3. Eyre, Harris A.; Lavretsky, Helen; Forbes, Malcolm; Raji, Cyrus; Small, Gary; McGorry, Patrick; Baune, Bernhard T.; Reynolds, Charles (February 2017). "Convergence Science Arrives: How Does It Relate to Psychiatry?". Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry. 41 (1): 91–99. doi:10.1007/s40596-016-0496-0. ISSN 1042-9670. PMC 5540327. PMID 26964782.
  4. "Personalized Psychiatry - 1st Edition". www.elsevier.com. Retrieved 2019-12-01.
  5. "Doctor Q November 2013". Issuu. Retrieved 2019-12-01.
  6. Eyre, Harris A.; Vahabzadeh, Arshya; Abbott, Ryan; Cook, Ian A.; Berk, Michael (01 2018). "The Future of Psychiatry Commission". The Lancet. Psychiatry. 5 (1): 13. doi:10.1016/S2215-0366(17)30410-8. ISSN 2215-0374. PMID 29277199. Check date values in: |date= (help)
  7. Harris A Eyre; Malcolm Forbes; Cyrus Raji; Nicholas Cork; Steven Durning; Elizabeth Armstrong; Erica Wheeler; Arlen Meyers; Bernhard T Baune; Michael Berk (2015-12-02). "Strengthening the role of convergence science in medicine". Convergent Science Physical Oncology. 1 (2). doi:10.1088/2057-1739/1/2/026001/meta. ISSN 2057-1739.
  8. Eyre, Harris A.; Becker, Elisabeth R. B.; Blumenthal, Marissa S.; Singh, Ajeet B.; Raji, Cyrus; Vahabzadeh, Arshya; Wainer, Zoe; Bousman, Chad (2020-01-01), Baune, Bernhard T., ed., "Chapter 6 - Consumer participation in personalized psychiatry", Personalized Psychiatry, Academic Press, pp. 63–68, ISBN 978-0-12-813176-3, retrieved 2019-12-01
  9. Eyre, H. A.; Mitchell, R. D.; Milford, W.; Vaswani, N.; Moylan, S. (June 2014). "Portfolio careers for medical graduates: implications for postgraduate training and workforce planning". Australian health review : a publication of the Australian Hospital Association. 38 (3): 246–251. doi:10.1071/AH13203. ISSN 0156-5788. PMID 24718035.
  10. Eyre, Harris A; Robb, Andrew; Abbott, Ryan; Hopwood, Malcolm (2019-05-01). "Mental health innovation diplomacy: An under-recognised soft power". Australian & New Zealand Journal of Psychiatry. 53 (5): 474–475. doi:10.1177/0004867419828488. ISSN 0004-8674.
  11. "Charles F. Reynolds III", Wikipedia, 2019-11-04, retrieved 2019-12-01
  12. "Dr Harris Eyre". Outstanding Alumni Awards. Retrieved 2019-12-01.
  13. "Dr Harris Eyre: a multi-faceted career while at UCLA". Fulbright. 2015-09-21. Retrieved 2019-12-01.
  14. "Barwon Health", Wikipedia, 2019-11-12, retrieved 2019-12-01
  15. "Townsville Hospital", Wikipedia, 2019-11-11, retrieved 2019-12-01
  16. "Royal Melbourne Hospital", Wikipedia, 2019-10-25, retrieved 2019-12-01
  17. Connection, The Victorian (2018-06-18). "CNSDose showcases DNA-guided depression treatment". connection.vic.gov.au. Retrieved 2019-12-01.
  18. Commission, Australian Trade and Investment. "CNSdose genetic tool makes personalised medicine a". www.austrade.gov.au. Retrieved 2019-12-01.
  19. Peterson, Kimberly; Dieperink, Eric; Anderson, Johanna; Boundy, Erin; Ferguson, Lauren; Helfand, Mark (June 2017). "Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder". Psychopharmacology. 234 (11): 1649–1661. doi:10.1007/s00213-017-4622-9. ISSN 1432-2072. PMID 28456840.
  20. "Texas Medical Center Announces $25 Million TMC Venture Fund". TMC News. 2017-11-08. Retrieved 2019-12-01.
  21. "Harris Eyre - Google Scholar Citations". scholar.google.com.au. Retrieved 2019-12-01.
  22. Eyre, Harris A; Robb, Andrew; Abbott, Ryan; Hopwood, Malcolm (2019-05-01). "Mental health innovation diplomacy: An under-recognised soft power". Australian & New Zealand Journal of Psychiatry. 53 (5): 474–475. doi:10.1177/0004867419828488. ISSN 0004-8674.
  23. Eyre, H. A.; Stuart, M. J.; Baune, B. T. (2014-10-03). "A phase-specific neuroimmune model of clinical depression". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 54: 265–274. doi:10.1016/j.pnpbp.2014.06.011. ISSN 1878-4216. PMID 24999185.
  24. Eyre, Harris A.; Air, Tracy; Pradhan, Alyssa; Johnston, James; Lavretsky, Helen; Stuart, Michael J.; Baune, Bernhard T. (2016-07-04). "A meta-analysis of chemokines in major depression". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 68: 1–8. doi:10.1016/j.pnpbp.2016.02.006. ISSN 1878-4216. PMC 5536843. PMID 26903140.
  25. Bousman, Chad A.; Arandjelovic, Katarina; Mancuso, Serafino G.; Eyre, Harris A.; Dunlop, Boadie W. (01 2019). "Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials". Pharmacogenomics. 20 (1): 37–47. doi:10.2217/pgs-2018-0142. ISSN 1744-8042. PMID 30520364. Check date values in: |date= (help)
  26. Eyre, Harris A.; Siddarth, Prabha; Acevedo, Bianca; Van Dyk, Kathleen; Paholpak, Pattharee; Ercoli, Linda; St Cyr, Natalie; Yang, Hongyu; Khalsa, Dharma S.; Lavretsky, Helen (04 2017). "A randomized controlled trial of Kundalini yoga in mild cognitive impairment". International Psychogeriatrics. 29 (4): 557–567. doi:10.1017/S1041610216002155. ISSN 1741-203X. PMC 5540331. PMID 28088925. Check date values in: |date= (help)
  27. Eyre, Harris A.; Lavretsky, Helen; Forbes, Malcolm; Raji, Cyrus; Small, Gary; McGorry, Patrick; Baune, Bernhard T.; Reynolds, Charles (February 2017). "Convergence Science Arrives: How Does It Relate to Psychiatry?". Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry. 41 (1): 91–99. doi:10.1007/s40596-016-0496-0. ISSN 1042-9670. PMC 5540327. PMID 26964782.
  28. "People". Stanford Brainstorm. Retrieved 2019-12-01.
  29. Reynolds, Gretchen (2016-06-01). "Yoga May Be Good for the Brain". Well. Retrieved 2019-12-01.
  30. EDT, Dana Dovey On 4/13/18 at 12:58 PM (2018-04-13). "Sitting for too many hours is associated with thinning of the brain area linked to memory". Newsweek. Retrieved 2019-12-01.
  31. "Ex Trade Minister Andrew Robb to advise genetic testing startup CNSDose". Australian Financial Review. 2016-07-11. Retrieved 2019-12-01.
  32. "TMCx builds bridges to Australia's health tech sector". HoustonChronicle.com. 2018-02-22. Retrieved 2019-12-01.
  33. "Harris Eyre". Forbes. Retrieved 2019-12-01.
  34. "Dr Harris Eyre: a multi-faceted career while at UCLA". Fulbright. 2015-09-21. Retrieved 2019-12-01.
  35. "Australian of the Year Awards". www.australianoftheyear.org.au. Retrieved 2019-12-01.


This article "Harris Eyre" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Harris Eyre. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

Page kept on Wikipedia This page exists already on Wikipedia.